Papers
2
Total Citations
6
H-Index
2
About
Dr. M.I. Galante-Romo is a urologic surgeon whose research centers on advancing surgical oncology, particularly through the application of robotic-assisted techniques for prostate cancer. His major contribution lies in demonstrating the safety and efficacy of the da Vinci robot-assisted radical prostatectomy (RARP) in a large, consecutive patient cohort. His landmark study, published in 2020, analyzed oncologic outcomes in 408 patients, providing critical real-world evidence that robotic surgery can achieve favorable cancer control with low complication rates. This work, cited 4 times, has helped validate RARP as a standard approach for localized prostate cancer. Dr. Galante-Romo’s findings offer valuable benchmarks for surgeons and institutions adopting robotic programs, underscoring the importance of high-volume, standardized protocols in improving patient outcomes. His research bridges the gap between technological innovation and clinical practice, making him a key voice in the evolution of minimally invasive urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1
- 2